Skip to main content

Peer Review reports

From: Efficacy and safety of HIP1601 (dual delayed-release esomeprazole) 40 mg in erosive esophagitis compared to HGP1705 (delayed-release esomeprazole) 40 mg: a multicenter, randomized, double-blind, non-inferiority study

Original Submission
30 Aug 2023 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
24 Oct 2023 Reviewed Reviewer Report
1 Nov 2023 Reviewed Reviewer Report
11 Nov 2023 Author responded Author comments - Hwoon-Yong Jung
Resubmission - Version 4
11 Nov 2023 Submitted Manuscript version 4
19 Nov 2023 Author responded Author comments - Hwoon-Yong Jung
Resubmission - Version 5
19 Nov 2023 Submitted Manuscript version 5
25 Nov 2023 Author responded Author comments - Hwoon-Yong Jung
Resubmission - Version 6
25 Nov 2023 Submitted Manuscript version 6
29 Nov 2023 Reviewed Reviewer Report
10 Dec 2023 Reviewed Reviewer Report
Resubmission - Version 7
Submitted Manuscript version 7
Publishing
10 Dec 2023 Editorially accepted
18 Dec 2023 Article published 10.1186/s12876-023-03087-6

You can find further information about peer review here.

Back to article page